Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: Larry Liebman who wrote (242)	12/21/1999 2:29:00 AM
From: sasha4477	Respond to of 359

The speculation for the strength in some of the biotech informatic type stocks this day is a rather compelling clear explanation in the New York Times Monday of the how the science will apply the knowledge gained from all the research and genomic mapping taking place. I found the article to be the best explanation of the broad trends and their practical application that I have read to date. I suggest everyone read it. No companies are mentioned but the implications are clear for anyone who has done some DD with respect to the bigger names in the field. What I find encouraging is that our little low volume stock was apparently on people's radar screen even though it hasnt fully enjoyed the runnups of the others of late. Considering no names were mentioned in the article someone knew where to look to find us. Whether or not we hold at these levels in the short term doesnt matter. There was triple normal volume today and that means the world is finding their way here. I would appreciate comments from the scientifically and technically inclined who read the NY Times article. Good Luck